Pros | ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() Larger AUM within category. ![]() 5Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y. | ||
Cons | - | - |
INDMoney rank | - | 6/19 | ||
Category,Subcateogry | Equity,Mid-Cap | Equity,Mid-Cap | ||
Fund Age | 7 Years | 12 Years | ||
Fund Size | 3776 Cr | 53464 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹1000 | SIP ₹100 Lumpsum ₹100 | ||
Expense Ratio | 0.45% | 0.42% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | Nifty Midcap 150 TR INR | Nifty Midcap 150 TR INR |
No of Holdings | 72 | 63 | ||
Top 5 Holdings | Max Healthcare Institute Ltd Ordinary Shares (3.28%) Indian Bank (2.6%) Tube Investments of India Ltd Ordinary Shares (2.5%) APL Apollo Tubes Ltd (2.3%) Bharti Hexacom Ltd (2.13%) | Solar Industries India Ltd (3.33%) Fortis Healthcare Ltd (3.27%) Ipca Laboratories Ltd (3.03%) Mphasis Ltd (2.99%) GE Vernova T&D India Ltd (2.97%) | ||
No of Sectors | 10 | 13 | ||
Top 3 Sectors | Financial Services (19.26%) Industrial (16.19%) Consumer Cyclical (16.09%) | Consumer Cyclical (18.7%) Industrial (16.56%) Tech (15.5%) | ||
Equity % | 97.34% | 94.04% | ||
Debt % | - | - | ||
P/E | 25.28 | 31.04 | ||
P/B | 3.44 | 4.99 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 3.71% | 5.81% | ||
3-Month Return | 10.93% | 15.21% | ||
6-Month Return | 1.87% | 2.13% | ||
1-Year Return | 5.32% | 9.02% | ||
3-Year Return | 31.83% | 28.9% | ||
5-Year Return | 31.9% | 32.15% |
Sharpe | 1.2 | 1.06 | ||
Alpha | 1.87 | 0.27 | ||
Beta | 0.95 | 0.9 | ||
Standard Deviation | 16.5 | 16.24 | ||
Information Ratio | 0.45 | -0.32 |
Description | Mahindra Manulife Mid Cap Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Kotak Emerging Equity Scheme Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Krishna Sanghavi,Manish Lodha | Atul Bhole |